NCT05945875View on ClinicalTrials.gov

Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 3, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
Interventions
DRUG

Panitumumab-IRDye800

Given by IV

OTHER

Indium In 111 Panitumumab

Given by IV

PROCEDURE

Single Photon Emission Computed Tomography

Undergo Single Photon Emission Computed Tomography

PROCEDURE

Computed Tomography

Undergo Computed Tomography

PROCEDURE

Resection

Undergo standard of care surgical resection

PROCEDURE

Fluorescence Imaging

Undergo standard of care fluorescence imaging

Trial Locations (1)

37203

RECRUITING

Vanderbilt University/Ingram Cancer Center, Nashville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Vanderbilt-Ingram Cancer Center

OTHER